🇨🇦 Extended half-life FVIII concentrates with PK-guided dosing in Canada

Extended half-life FVIII concentrates with PK-guided dosing (Extended half-life FVIII concentrates with PK-guided dosing) regulatory status in Canada.

Marketing authorisation

Extended half-life FVIII concentrates with PK-guided dosing in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Extended half-life FVIII concentrates with PK-guided dosing approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Extended half-life FVIII concentrates with PK-guided dosing in Canada?

Chulalongkorn University is the originator. The local marketing authorisation holder may differ — check the official source linked above.